CoChat

Identification and characterization of IL-10/IFN-γ–producing effector-like T cells with regulatory function in human blood

Open access
Häringer, Barbara, Lozza, Laura, Steckel, Bodo, Geginat, Jens · 2009 · Journal of Experimental Medicine

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Two subsets of natural and adaptive regulatory T (T reg) cells have been described, but the identity of adaptive type 1 regulatory (Tr1)–like cells in humans is unclear. We analyzed a subset of human blood CD4+ T cells—CD45RA−CD25−interleukin (IL)-7 receptor (R)− cells—that rapidly secreted high levels of IL-10 together with interferon γ, but produced little IL-2. These IL-7R− T cells were rare, anergic, and largely Foxp3−. They expressed low levels of Bcl-2 but high levels of Ki-67 and ICOS, suggesting that they have been recently activated in vivo. Consistently, they responded selectively to persistent foreign and self-antigens under steady-state conditions. Unlike natural CD25+ T reg cells, IL-7R− cells suppressed naive and memory T cell proliferation in an IL-10–dependent fashion, and they required strong T cell receptor stimulation for suppression. To our knowledge, this is the first report that identifies Tr1-like cells in human blood. These IL-10–secreting cells have characteristics of chronically activated Th1 effector cells and are distinct from CD25+ T reg cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20082238

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Tr1-like cytokine profile of CD25−IL-7R− T cells. (A) CD25 and IL-7Rα expression on antigen-experienced human blood CD4+CD45RA− T cells ex vivo. (B) Foxp3 expression in CD4+ T cell subsets purified according to CD25 and IL-7Rα expression assessed once in at least 11 different donors. (C) Purified CD25−IL-7R− and IL-7R+ subsets were stimulated with anti-CD3 and anti-CD28 antibodies or with phorbol 12,13-dibutyrate (PdBu) plus ionomycin, and IL-10 and IL-2 secretion were measured (percentages are shown). One representative experiment out of seven with seven different donors is shown. (D) Total CD4+CD45RA− cells were compared with subsets defined by CD25 and IL-7R expression for the secretion of IL-10 and IFN-γ (top), IL-4 (middle), and IL-17 (bottom). Percentages are shown. One representative experiment out of three performed with four different donors is shown. (E) Percentages of total IFN-γ+ cells (left), total IL-10+ cells (middle), and IFN-γ–producing cells among IL-10+ cells (right) in IL-7R−, IL-7R+, and CD25+ subsets in 13 different donors. Horizontal bars represent means. *, P < 0.05; and **, P < 0.005.
Figure 1. Tr1-like cytokine profile of CD25−IL-7R− T cells. (A) CD25 and IL-7Rα expression on antigen-experienced human blood CD4+CD45RA− T cells ex vivo. (B) Foxp3 expression in CD4+ T cell subsets purified according to CD25 and IL-7Rα expression assessed once in at least 11 different donors. (C) Purified CD25−IL-7R− and IL-7R+ subsets were stimulated with anti-CD3 and anti-CD28 antibodies or with phorbol 12,13-dibutyrate (PdBu) plus ionomycin, and IL-10 and IL-2 secretion were measured (percentages are shown). One representative experiment out of seven with seven different donors is shown. (D) Total CD4+CD45RA− cells were compared with subsets defined by CD25 and IL-7R expression for the secretion of IL-10 and IFN-γ (top), IL-4 (middle), and IL-17 (bottom). Percentages are shown. One representative experiment out of three performed with four different donors is shown. (E) Percentages of total IFN-γ+ cells (left), total IL-10+ cells (middle), and IFN-γ–producing cells among IL-10+ cells (right) in IL-7R−, IL-7R+, and CD25+ subsets in 13 different donors. Horizontal bars represent means. *, P < 0.05; and **, P < 0.005.CC BY-NC-SA · PubMed Central
Figure 2. Low expansion potential of IL-7R− T cells in response to TCR stimulation and homeostatic cytokines. (A) Proliferative response of subsets purified according to CD25 and IL-7Rα expression in response to anti-CD3 antibodies in the absence or presence of exogenous IL-2 or co-stimulatory anti-CD28 antibodies. CFSE dilution of viable cells was assessed on day 4. One representative donor out of three is shown. (B) Proliferative response of subsets purified according to CCR7 and IL-7Rα expression in response to 25 ng/ml IL-7 or IL-15 on day 7. One representative donor out of four is shown. (C) The recovered number of cells after stimulation with IL-7, IL-15, or anti-CD3/28. Horizontal bars represent means. *, P < 0.05.
Figure 2. Low expansion potential of IL-7R− T cells in response to TCR stimulation and homeostatic cytokines. (A) Proliferative response of subsets purified according to CD25 and IL-7Rα expression in response to anti-CD3 antibodies in the absence or presence of exogenous IL-2 or co-stimulatory anti-CD28 antibodies. CFSE dilution of viable cells was assessed on day 4. One representative donor out of three is shown. (B) Proliferative response of subsets purified according to CCR7 and IL-7Rα expression in response to 25 ng/ml IL-7 or IL-15 on day 7. One representative donor out of four is shown. (C) The recovered number of cells after stimulation with IL-7, IL-15, or anti-CD3/28. Horizontal bars represent means. *, P < 0.05.CC BY-NC-SA · PubMed Central
Figure 3. Antigen specificities of IL-7R− T cells. (A) CFSE profiles of CD25−IL-7R− and IL-7R+ subsets in one donor after stimulation in the absence or presence of protein antigens derived from HCMV, MelanA, and TT on day 7. (B) Percentages of purified IL-7R− and IL-7R+ cells that have diluted CFSE on day 7 in at least 20 different donors in response to HCMV (14 donors), C. albicans (Candida; 7 donors), MelanA (8 donors), influenza hemagglutinin (Flu; 6 donors), M. tuberculosis (PPD; 7 donors), and TT (6 donors). Significantly lower proliferation among IL-7R− cells is indicated (*, P < 0.05; and **, P < 0.005). (C) IFN-γ versus IL-10 production of cells that had divided in response to HCMV or Candida in IL-7R+ and IL-7R− subsets after restimulation with the relevant antigen. One representative experiment with different donors out of three (Candida) or five (HCMV) is shown.
Figure 3. Antigen specificities of IL-7R− T cells. (A) CFSE profiles of CD25−IL-7R− and IL-7R+ subsets in one donor after stimulation in the absence or presence of protein antigens derived from HCMV, MelanA, and TT on day 7. (B) Percentages of purified IL-7R− and IL-7R+ cells that have diluted CFSE on day 7 in at least 20 different donors in response to HCMV (14 donors), C. albicans (Candida; 7 donors), MelanA (8 donors), influenza hemagglutinin (Flu; 6 donors), M. tuberculosis (PPD; 7 donors), and TT (6 donors). Significantly lower proliferation among IL-7R− cells is indicated (*, P < 0.05; and **, P < 0.005). (C) IFN-γ versus IL-10 production of cells that had divided in response to HCMV or Candida in IL-7R+ and IL-7R− subsets after restimulation with the relevant antigen. One representative experiment with different donors out of three (Candida) or five (HCMV) is shown.CC BY-NC-SA · PubMed Central
Figure 4. Activation marker expression in IL-7R− T cell subsets. CD4+CD45RA− T cell subsets identified by CD25 and IL-7Rα expression were analyzed once in at least seven healthy donors for the expression of (A) Ki-67, (B) ICOS, or (C) HLA-DR. Significant differences are indicated (**, P < 0.005). Horizontal bars represent means. (D and E) Intracellular expression of (D) Bcl-2 ex vivo and (E) CTLA-4 after stimulation of purified subsets. Histogram plots are representative of single experiments in at least three different donors.
Figure 4. Activation marker expression in IL-7R− T cell subsets. CD4+CD45RA− T cell subsets identified by CD25 and IL-7Rα expression were analyzed once in at least seven healthy donors for the expression of (A) Ki-67, (B) ICOS, or (C) HLA-DR. Significant differences are indicated (**, P < 0.005). Horizontal bars represent means. (D and E) Intracellular expression of (D) Bcl-2 ex vivo and (E) CTLA-4 after stimulation of purified subsets. Histogram plots are representative of single experiments in at least three different donors.CC BY-NC-SA · PubMed Central
Figure 5. Different requirements for suppression of CD25+ T reg cells and IL-7R− cells. (A and B) CFSE-labeled SEB-hyporesponsive naive T cells were stimulated with DCs pulsed with TSST and different amounts of SEB in the presence of different TSST hyporesponsive T cell populations. Open histograms show CFSE profiles of TCR-Vβ2+ responder cells when naive control cells were present, whereas shaded histograms show the effects of the presence of IL-7R− cells (top) or of CD25+ T reg cells (bottom). (A) CFSE profiles in the absence or presence of 50 pg/ml (low) or 1 ng/ml (high) SEB are representative of four independent experiments with different donors. (B) Suppression of naive cells (representative of 14 donors; left) or of IL-7R+ memory cells (representative of 6 donors; right) in the absence or presence of IL-10 neutralization induced by CCR4−IL-7R− cells (top) or by CD25+ T reg cells (bottom). (C) Suppression induced by CCR4−IL-7R− cells (left) and by CD25+ T reg cells (right) in 14 different donors in the absence or presence of IL-10 neutralization. (D) Effects of T reg cell dilution on suppression in the absence or presence of anti–IL-10. The means of six independent experiments are shown.
Figure 5. Different requirements for suppression of CD25+ T reg cells and IL-7R− cells. (A and B) CFSE-labeled SEB-hyporesponsive naive T cells were stimulated with DCs pulsed with TSST and different amounts of SEB in the presence of different TSST hyporesponsive T cell populations. Open histograms show CFSE profiles of TCR-Vβ2+ responder cells when naive control cells were present, whereas shaded histograms show the effects of the presence of IL-7R− cells (top) or of CD25+ T reg cells (bottom). (A) CFSE profiles in the absence or presence of 50 pg/ml (low) or 1 ng/ml (high) SEB are representative of four independent experiments with different donors. (B) Suppression of naive cells (representative of 14 donors; left) or of IL-7R+ memory cells (representative of 6 donors; right) in the absence or presence of IL-10 neutralization induced by CCR4−IL-7R− cells (top) or by CD25+ T reg cells (bottom). (C) Suppression induced by CCR4−IL-7R− cells (left) and by CD25+ T reg cells (right) in 14 different donors in the absence or presence of IL-10 neutralization. (D) Effects of T reg cell dilution on suppression in the absence or presence of anti–IL-10. The means of six independent experiments are shown.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 172

Metadata

Authors
Häringer, B., Lozza, L., Steckel, B., & Geginat, J.
Affiliations
German Rheumatism Research Centre (DE)
Corresponding author
Geginat, Jens
Venue
Journal of Experimental Medicine
Published
2009-05-04
Volume
206
Issue
5
Pages
1009-1017
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W1998077939
Cited by
150
References
30
Citations by year
2025: 2 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 6 · 2019: 4 · 2018: 10 · 2017: 3 · 2016: 11 · 2015: 11 · 2014: 10 · 2013: 13 · 2012: 18
FWCI
8.18
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
Funders
Deutsche Forschungsgemeinschaft (SFB 650)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
type 1 regulatory T cells, IL-10, interferon-gamma, CD4+ T cells, T cell suppression, ICOS, Ki-67, Bcl-2, T cell receptor stimulation, persistent antigen, CD25+ regulatory T cells
MeSH terms
Autoantigens, Humans, Interferon-gamma, Interleukin-2, Lymphocyte Activation, T-Lymphocytes, Antigens, CD, T-Lymphocyte Subsets, Interleukin-10, Genes, T-Cell Receptor, Receptors, Interleukin-7, T-Lymphocytes, Regulatory, Interleukin-2 Receptor alpha Subunit, Receptors, CCR7

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.